Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004347:Drug Interactions; D011464:Epoprostenol / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D013806:Theophylline; D011464:Epoprostenol; D013917:Thrombin